Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Obesity

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Obesity in 1 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morales-Cano, D1
Callejo, M1
Barreira, B1
Mondejar-Parreño, G1
Esquivel-Ruiz, S1
Ramos, S1
Martín, MÁ1
Cogolludo, A1
Moreno, L1
Perez-Vizcaino, F1

Other Studies

1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Obesity

ArticleYear
Elevated pulmonary arterial pressure in Zucker diabetic fatty rats.
    PloS one, 2019, Volume: 14, Issue:1

    Topics: Amidines; Animals; Arterial Pressure; Benzylamines; Blood Glucose; Bone Morphogenetic Protein Recept

2019